Peter Bader

Goethe University Frankfurt — Germany

Medicine · Health Sciences

74h-index26.4kcitations574works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(266), Acute Lymphoblastic Leukemia research(188), CAR-T cell therapy research(109), Acute Myeloid Leukemia Research(86), Childhood Cancer Survivors' Quality of Life(75)

Publications573 total

Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival – an EBMT PDWP retrospective study
Bone Marrow Transplantation·2025
Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT
Blood·2025
Comparison of outcomes in pediatric patients with acute leukemia undergoing allogeneic HLA-haploidentical hematopoietic stem cell transplantation (HSCT) after in vitro a/b T- and CD19-cell depletion or In Vivo administration of post-transplant cyclophosphamide: An EBMT pediatric working party study
Blood·2025Open Access
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP
Bone Marrow Transplantation·2025
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group
Transplantation and Cellular Therapy·2025Open Access
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
Haematologica·2025· 1 citedOpen Access
Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients
Journal of Human Immunity·2025· 10 citedOpen Access
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
Frontiers in Immunology·2025· 8 citedOpen Access
Excellent Outcomes in Patients Receiving Tisagenlecleucel for R/R B-Cell ALL: Results from the European Post-Authorization Safety Study (PASS), on Behalf of the Ctiwp, PDWP and ALWP of the EBMT.
Transplantation and Cellular Therapy·2025· 1 cited
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults
Journal of Hematology & Oncology·2025· 4 citedOpen Access
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP
Blood Advances·2025· 2 citedOpen Access
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study
Cancers·2025· 7 citedOpen Access
The expressions of myeloid differentiation and non-lineage specific differentiation antigens among FAB subtypes of acute myeloid leukemia in Iraqi patients
Romanian Medical Journal·2024Open Access
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
Blood Advances·2024· 2 citedOpen Access
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study
Leukemia·2024· 9 cited
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials
British Journal of Clinical Pharmacology·2024Open Access
Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study
Blood·2024
Total Body Irradiation Versus Chemotherapy Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia Patients Aged 2 to 4 Years: A Retrospective Study of the EBMT Pediatric Diseases Working Party
Blood·2024Open Access
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Outcomes in Leukocyte Adhesion Deficiency Type -I
Blood·2024Open Access
Eight induced pluripotent stem cell lines (iPSCs) derived from two patients with Leukocyte adhesion deficiency Type I (LAD I) with mutations in the ITGB2 gene
Stem Cell Research·2024Open Access
page 1 of 29Next →

Frequent Co-authors

Christina Peters(14), Mohamad Mohty(14), Thomas Klingebiel(13), Rupert Handgretinger(12), Arnon Nagler(12), Rafael F. Duarte(12), D. Niethammer(12), Peter Lang(10), Nicolaus Kröger(10), Hermann Kreyenberg(10), Selim Corbacioglu(9), Carlo Dufour(9), Jürgen Kuball(9), John A. Snowden(8), Jan Styczyński(8), Ibrahim Yakoub‐Agha(7), Chiara Bonini(7), Grzegorz Basak(7), Johann Greil(7), Arend von Stackelberg(6)